首页> 外国专利> IL-21 (HETERODIMERIC FC-FUSED IL-21) FUSED TO IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION HETERODIMER (HETERODIMERIC FC), AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

IL-21 (HETERODIMERIC FC-FUSED IL-21) FUSED TO IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION HETERODIMER (HETERODIMERIC FC), AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

机译:融合至免疫球蛋白重链恒定区异二聚体(异二聚体FC)和组成相同的药物成分的IL-21(异二聚体FC融合IL-21)

摘要

A heterodimeric Fc-fused protein and a pharmaceutical composition comprising the heterodimeric Fc-fused protein are disclosed. The heterodimeric Fc-fused protein comprises first and second Fc regions of an immunoglobulin heavy chain constant region (Fc) pair and in which IL-21 is bound to at least one of the N-terminus or the C-terminus of the first Fc region and/or the second Fc region, wherein CH3 domains of the first Fc region and the second Fc region are mutated such that the formation of a heterodimer is promoted.;When the heterodimeric Fc-fused protein according to the present invention is used, an in vivo half-life of IL-21 included in the heterodimeric Fc-fused protein may be significantly increased.
机译:公开了异二聚体Fc融合蛋白和包含异二聚体Fc融合蛋白的药物组合物。异二聚体Fc融合蛋白包含免疫球蛋白重链恒定区(Fc)对的第一和第二Fc区,并且其中IL-21结合至第一Fc区的N端或C端中的至少一个和/或第二Fc区,其中第一Fc区和第二Fc区的CH3结构域被突变以促进异二聚体的形成。;当使用根据本发明的异二聚体Fc融合蛋白时,包含在异二聚体Fc融合蛋白中的IL-21的体内半衰期可能会大大延长。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号